David Mehalick's Net Worth
$518 Thousand
Who is David Mehalick?
David Mehalick does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Coeptis Therapeutics Inc., and Coeptis Therapeutics Holdings, Inc..
SEC CIK
David Mehalick's CIK is 0001846623
Past Insider Trading and Trends
2024 was David Mehalick's most active year for acquiring shares with 3 total transactions. David Mehalick's most active month to acquire stocks was the month of December. 2021 was David Mehalick's most active year for disposing of shares, totalling 1 transactions. David Mehalick's most active month to dispose stocks was the month of October. 2024 saw David Mehalick paying a total of $16,747.14 for 25,054 shares, this is the most they've acquired in one year. In 2021 David Mehalick cashed out on 1,200,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Coeptis Therapeutics Inc. No price found
CEO and PresidentDavid Mehalick owns 1,800,000 units of Common Stock. In the year 2021 David Mehalick filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -40.00% | -1.20M |
—
|
—
| 1.8M |
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Coeptis Therapeutics Holdings, Inc. (COEP) Snapshot price: $0.192
CEO and PresidentDavid Mehalick owns 2,782,615 units of Common Stock which is worth $534,262.08. In the year 2023 David Mehalick acquired a total of 25,054 shares in Coeptis Therapeutics Holdings, Inc. at a cost of $16,747.14, David also disposed a total of 700,000 shares of Coeptis Therapeutics Holdings, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.91% | 25.05K |
$0.67 | $16,747.14 | 2.78M |
Jan 5 - Jan 8
| |||
Form 4
| -20.25% | -700.00K |
—
|
—
| 2.76M |
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||